학술논문

Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy
Document Type
Article
Source
In: Pediatric Nephrology. (Pediatric Nephrology, January 2024, 39(1):309-314)
Subject
Language
English
ISSN
1432198X
0931041X